(Q43029633)

English

Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

R Fukuda

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

N Ishimura

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

S Hamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Moritani

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Y Uchida

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

S Ishihara

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

S Akagi

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Watanabe

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Y Kinoshita

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

220-227

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Ligand-induced association of the type I interferon receptor components

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Dominant replication of either virus in dual infection with hepatitis viruses B and C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Upregulation of type I interferon receptor by IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

The human interferon alpha/beta receptor: characterization and molecular cloning

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Studies of the interferon receptors

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C220%3A%3AAID-JMV1004%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43029633&oldid=2100563446"